[...] There is a need to find new ways and financing mechanisms to support the development of innovative technologies and solutions for AHA, which can include private financing schemes, crowdfunding models, etc. It will be important to understand how the funding models can be extended to also cover the early stage of the commercialisation of technologies, and not only the Research and Innovation phases. This might be supported by impact assessment studies on the added-value of the current models. The importance of the private sector in the future of AHA was highlighted on a number of occasions during the discussions, as can be seen in Priority P2, when SAB members emphasised the importance of private sector skills. Also, SAB members stressed the importance of the integration of public and private funding and the threat of competing markets in China and the US. The role of the government in integrating the private sector in AHA is paramount to making it a success in the future. The right conditions within the industry need to be created, and there should be a focus on SMEs (P8-RIA5). Exploring the P8-RIA3, SAB members defended that the possible economic incentives of sharing medical data (e.g. Projects such as VISC+ in Cataluña, Spain) should be investigated along with the development of a network made up of public and private investors. Regarding P8-RIA4 they stressed that a metrics framework is needed to measure the quality of life implications as a tool to stimulate investment. These are metrics for companies and this can stimulate the systemic innovation. A shift from SMART targets to HARD targets is also needed. There are many existing technologies and solutions, let’s give these solutions some numbers (impacts).